儿童药品不良反应公众报告模式探索实践  

Exploration and Practice of the Public Reporting of Adverse Drug Reactions in Children

作　　者：范盾聪 孙丹青[1] 朱倩[1] Fan Duncong;Sun Danqing;Zhu Qian(Haining People’s Hospital,Zhejiang Haining 314400,China)

机构地区：[1]海宁市人民医院,浙江海宁314400

出　　处：《儿科药学杂志》2023年第5期27-30,共4页Journal of Pediatric Pharmacy

基　　金：浙江省医学会临床科研基金项目,编号2020ZYC-A123。

摘　　要：目的:探索建立药品不良反应(ADR)公众报告路径,推动儿童ADR监测工作。方法:采用问卷调查了解儿童家长对ADR的认知与报告意识,分析公众报告的需求,结合文献研究设计ADR公众报告路径,并在医疗机构及药品零售店实践。结果:儿童家长对ADR关注度高,报告意向强烈,经小范围试点收集有效报告15份。结论:公众报告路径是收集儿童ADR报告的重要渠道,应重视。可进一步总结实践结果,为后期全面推广公众上报提供参考。Objective:To establish a public reporting path for adverse drug reactions(ADR),and promote ADR monitoring for children.Methods:A questionnaire survey was carried out to understand the cognition and behavioral intention of ADR,and the needs of the public reporting of ADR were analyzed.Combined with literature research,the public reporting path for ADR was designed and practiced in medical institutions and drug retail stores.Results:Parents paid high attention to ADR,with strong intention to report,and 15 effective reports were collected through small-scale pilot projects.Conclusion:The public reporting path is an important channel for collecting childhood ADR reports and should be valued.The practical results can be further summarized and improved to provide reference for the comprehensive promotion of public reporting in the later period.

关 键 词：儿童 药品不良反应 公众报告 

分 类 号：R95[医药卫生—药学]